WINDTREE THERAPEUTICS INC /DE/
Income Statement
| Line Item | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $198.0K | $1.8M | $1.5M | $2.0M | $987.0K | $2.8M | $388.0K | $195.0K |
| Cost of Revenue | — | — | — | — | $929.0K | $2.7M | $517.0K | $0 |
| Gross Profit | — | — | — | — | $58.0K | $164.0K | $-129.0K | $195.0K |
| Gross Margin | — | — | — | — | 5.9% | 5.8% | -33.2% | 100.0% |
| Operating Expenses | ||||||||
| Research & Development | $12.7M | $10.6M | $17.4M | $31.7M | $28.9M | $26.7M | $27.7M | $21.6M |
| SG&A Expense | $12.4M | $7.4M | $6.7M | $8.4M | $11.0M | $16.7M | $16.7M | $16.4M |
| Operating Income | $-24.9M | $-16.2M | $-22.5M | $-38.0M | $-39.8M | $-43.3M | $-44.5M | $-37.8M |
| Operating Margin | -12,572.2% | -905.8% | -1,518.4% | -1,862.7% | -4,035.9% | -1,525.9% | -11,471.1% | -19,394.4% |
| Interest Expense | $495.0K | $1.4M | $1.9M | $2.5M | $4.6M | $4.6M | $9.0K | $13.0K |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | $0 | $0 | $0 | $0 |
| Net Income | $-27.5M | $-20.5M | $-18.4M | $-39.5M | $-55.2M | $-44.1M | $-45.2M | $-37.3M |
| Net Margin | -13,876.3% | -1,148.4% | -1,242.2% | -1,933.9% | -5,589.7% | -1,554.1% | -11,653.4% | -19,135.9% |
| EPS (Basic) | $-0.03 | $-0.09 | $-0.07 | $-0.01 | $-0.02 | $-0.02 | $0.00 | $0.00 |
| EPS (Diluted) | $-0.03 | $-0.09 | $-0.07 | $-0.01 | $-0.02 | $-0.02 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 1.15B | 377.4M | 345.4M | 2.80B | 2.34B | 2.04B | 18.57B | 13.24B |
| Shares Outstanding (Diluted) | 1.15B | 377.4M | 345.4M | 2.80B | 2.34B | 2.06B | 18.57B | 13.24B |
| Dividends Per Share | — | — | — | — | — | — | — | — |